The University of Cambridge is an associate member of the EIT Health, which allows us to bid for up to 750,000 euros each year to carry out innovation, education and entrepreneurship-related projects in collaboration with other EIT Health partners. The 2018 budget was 57M Euros and is from H2020 funding. The funding scheme requires match-funding: 25% EIT funding + 75% complementary activities. These complementary activities are eligible costs that will contribute towards the total budget of the project as in-kind contributions or co-funding and can be past project- related funding dated back to 09/12/2014 from internal Cambridge University funding or any previous grants. The scope of the call includes early intervention, prevention and altering disease course trajectories under the ‘Healthy Living’ theme. The call for 2019 projects opens on 12th February and closes on 9th April. It is a two stage application process with a 1st stage online form and 2nd stage pitch in person in Munich in June. See details in attached document
The Innovation by Ideas projects are to validate/de-risk a technology from prototype towards launch (launch ideally within 2 years of end of project) and should be TRL5-7 (i.e. not early stage research) however, clinical trials are not funded. Innovation by Design projects build on multidisciplinary collaboration, starting from a recognised market need. A project lasts 12-36 months and is required to have partners across at least 2 European Centres (CLCs) and needs 1 academic and 1 non-academic partner as listed here. Success rate for obtaining grants in the Innovations call is 20%. There are also calls for education (Campus) and Entrepreneurship included here.
Previous projects funded in the early detection of cancer/ risk stratification are
an early lung cancer diagnostic https://www.eithealth.eu/en_US/lucinda-early-lung-cancer-diagnosis and
individualized prostate cancer risk algorithm https://www.eithealth.eu/en_US/sthlm3rs
The non-academic partner can be a hospital, business, municipality or NGO. Relevant business partners include GE Healthcare, Beckton Dickinson, Siemens, Roche Diagnostics, Barco (Imaging), Janssen-Cilag GmBH. Medtronics is a UK-Ireland partner so a further European partner would be required. However, please note that Cambridge University Hospitals NHS Trust is not an EIT Health member, and as such they cannot lead a proposal and are not counted when it comes to eligibility of EIT Health proposals. EIT staff can assist in identifying and introducing potential partners and there is a joint meeting of London/Ireland and Germany centres in London on 13th March.
Further information can be obtained from:
Mercedes Hernandez, PhD | EIT KIC Coordinator, Mercedes.Hernandez-Gomez@admin.cam.ac.uk, University of Cambridge Research Operations Office on 012237 48049 | 012237 67827, or from Alexis Pacquit, EIT Health Innovation manager, email@example.com EIT Health London Office, 0203 865 1741